首页> 美国卫生研究院文献>Cancer Management and Research >Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management
【2h】

Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management

机译:细胞周期相关 lncRNA 作为推进癌症管理的创新靶点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long non-coding RNAs (lncRNAs) are non-coding RNAs (ncRNAs) longer than 200nt. They have complex biological functions and take part in multiple fundamental biological processes, such as cell proliferation, differentiation, survival and apoptosis. Recent studies suggest that lncRNAs modulate critical regulatory proteins involved in cancer cell cycle, such as cyclin, cell cycle protein-dependent kinases (CDK) and cell cycle protein-dependent kinase inhibitors (CKI) through different mechanisms. To clarify the role of lncRNAs in the regulation of cell cycle will provide new ideas for design of antitumor therapies which intervene with the cell cycle progression. In this paper, we review the recent studies about the controlling of lncRNAs on cell cycle related proteins such as cyclin, CDK and CKI in different cancers. We further outline the different mechanisms involved in this regulation and describe the emerging role of cell cycle-related lncRNAs in cancer diagnosis and therapy.
机译:长链非编码 RNA (lncRNA) 是长度超过 200nt 的非编码 RNA (ncRNA)。它们具有复杂的生物学功能,并参与多种基本生物过程,例如细胞增殖、分化、存活和细胞凋亡。最近的研究表明,lncRNAs 通过不同的机制调节参与癌细胞周期的关键调节蛋白,如细胞周期蛋白、细胞周期蛋白依赖性激酶 (CDK) 和细胞周期蛋白依赖性激酶抑制剂 (CKI)。阐明 lncRNAs 在细胞周期调节中的作用将为设计干预细胞周期进程的抗肿瘤疗法提供新思路。在本文中,我们回顾了近年来关于在不同癌症中控制 lncRNAs 对细胞周期相关蛋白(如 cyclin、CDK 和 CKI)的研究。我们进一步概述了这种调节所涉及的不同机制,并描述了细胞周期相关 lncRNAs 在癌症诊断和治疗中的新兴作用。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号